An innovative genetic test that can help prevent newborn babies from going deaf if treated with a common antibiotic, is now being used in routine clinical practice in maternity settings at MFT.
Researchers tell an international conference that a new gene therapy for Sanfilippo disease – also known as childhood dementia – has shown promising early results in a proof-of-concept study.
A 20-month-old baby girl has become the first child in the UK to receive a life-saving gene therapy treatment for the fatal disorder, metachromatic leukodystrophy disease (MLD).
A world-first genetic test to establish if a newborn baby is vulnerable to deafness if treated with a commonly used antibiotic, has been conditionally recommended by NICE.